Showing results (211-220 of 284) with videos related to

Sort By:
Pageof 29
Endoscopy International Open|July 18, 2022
EUS-guided biliary drainage with a novel electrocautery-enhanced lumen apposing metal stent as first approach for distal malignant biliary obstruction: a prospective studyBenedetto Mangiavillano, Jong Ho Moon, Antonio Facciorusso, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 4, 2011
A multicenter phase III prospective randomized trial of high-dose epirubicin in combination with cyclophosphamide (EC) versus docetaxel followed by EC in node-positive breast cancer. GOIM (Gruppo Oncologico Italia Meridionale) 9902 studyP Vici, M Brandi, F Giotta, et al.
Prostate Cancer and Prostatic Diseases|March 30, 2024
The diagnostic yield of the Meares & Stamey test can be significantly improved by symptom-based patient selection and the experience of the test performerTommaso Cai, Irene Tamanini, Katia Odorizzi, et al.
Molecular Microbiology|July 14, 2023
Negative regulation of MurZ and MurA underlies the essentiality of GpsB- and StkP-mediated protein phosphorylation in Streptococcus pneumoniae D39Ho-Ching Tiffany Tsui, Merrin Joseph, Jiaqi J Zheng, et al.
Nature Communications|January 18, 2019
The cell cycle regulator GpsB functions as cytosolic adaptor for multiple cell wall enzymesRobert M Cleverley, Zoe J Rutter, Jeanine Rismondo, et al.
Nature Communications|May 6, 2022
Transmembrane stem cell factor protein therapeutics enhance revascularization in ischemia without mast cell activationEri Takematsu, Miles Massidda, Jeff Auster, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2000
Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancerG Frasci, V Lorusso, N Panza, et al.
Diabetologia|January 1, 1997
Physiological and genetic characterization of the Gly40Ser mutation in the glucagon receptor gene in the Sardinian population. The Sardinian Diabetes Genetic Study GroupG Tonolo, M G Melis, M Ciccarese, et al.
Anticancer Research|August 19, 2007
5-year results of cisplatin-epirubicin-vinorelbine (PEV) combination as primary chemotherapy in T2-3, N0-2 breast cancer patients: a multicentre phase II studyS Barni, M Visini, E Piazza, et al.
International Journal of Oncology|May 17, 2000
Phase II study of induction chemotherapy followed by concomitant chemoradiotherapy in advanced head and neck cancer: clinical outcome, toxicity and organ/function preservationG Mantovani, A Maccio, E Massa, et al.
Pageof 29